Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
35–65
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male type II diabetes patients diagnosed for more than 5 years and aged between 35 and 65 years.
Subjects treated with metformin alone or metformin and one other oral anti-diabetic drug.
Subjects should have FPG in the range of 6.0 to 11.0 mmol/L at screening and HbA1c less than 10% (HbA1c value according to international DCCT standard).
You may not be if
History of ischemic heart disease, stroke, transient ischemic attack or symptomatic peripheral vascular disease.
Renal dysfunction.
Use of insulin, glitazones, warfarin and amiodarone within 3 months before enrolment and use of potent CYP450 inhibitors, e.g., ketoconazole and macrolide antibiotics within 14 days before administration of IP.